Keyphrases
Prognostic Factors
100%
Overall Survival
100%
Elderly Patients
100%
Treatment Outcome
100%
De Novo Acute Myeloid Leukemia
100%
Leukemia Patients
75%
Complete Remission
75%
Poor Prognostic Factors
50%
Acute Myeloid Leukemia
50%
Elderly Acute Myeloid Leukemia
50%
Risk Stratification
25%
Multivariate Analysis
25%
Comorbidity
25%
Clinical Trials
25%
Therapeutic Potential
25%
Clinical Course
25%
High Risk
25%
Performance Status
25%
Disease-free Survival
25%
Working Diagnosis
25%
Prognosis Outcome
25%
Thrombocytopenia
25%
Leukocytosis
25%
Low-risk Patients
25%
Conventional Chemotherapy
25%
Induction Chemotherapy
25%
Anthracyclines
25%
Upper Normal Limit
25%
Poor Performance Status
25%
Survival Duration
25%
Eastern Cooperative Oncology Group Performance Status (ECOG PS)
25%
Serum Lactate Dehydrogenase Level
25%
Performance Status Score
25%
Medicine and Dentistry
Overall Survival
100%
Elderly Patient
100%
Prognostic Factor
100%
Acute Myeloid Leukemia
100%
Leukocytosis
50%
Oncology
25%
Multivariate Analysis
25%
Disease Course
25%
Clinical Trial
25%
Lactate Dehydrogenase
25%
Mental Capacity
25%
Disease Free Survival
25%
Spontaneous Remission
25%
Thrombocytopenia
25%
Anthracycline
25%
Induction Chemotherapy
25%
Comorbidity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Acute Myeloid Leukemia
100%
De Novo Acute Myeloid Leukemia
100%
Remission
75%
Chemotherapy
50%
Leukocytosis
50%
Clinical Trial
25%
Disease Free Survival
25%
Lactate Dehydrogenase
25%
Disease Course
25%
Thrombocytopenia
25%
Anthracycline
25%
Comorbidity
25%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Overall Survival
80%
Clinical Trial
20%
Multivariate Analysis
20%
Disease Free Survival
20%
Mental Capacity
20%
Thrombocytopenia
20%
Anthracycline
20%
Lactate Dehydrogenase Blood Level
20%
Comorbidity
20%
Neuroscience
Myeloid
100%
Lactate Dehydrogenase
20%
Anthracycline
20%
Comorbidity
20%